McKesson Corporation vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? McKesson Corporation trades at $824.94 (market cap $97.35B), while Direxion Daily Semiconductor Bear 3X Shares trades at $45.05. The key difference: McKesson Corporation pays a 0.39% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| MCK | SOXS | |
|---|---|---|
Market Cap | $97.35B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $995.69 | $1.61K |
52-Week Low | $659.01 | $32.50 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% today, reflecting its inverse leveraged exposure to semiconductor stocks. Technical indicators show a bullish moving average signal but bearish oscillators with RSI levels above 96 suggesting extreme overbought conditions. Recent news highlights SOXS surging during semiconductor sell-offs, with a 1:10 stock split scheduled for July 26, 2026. The fund is designed for short-term tactical trades amid sector volatility.
The outlook for SOXS remains highly speculative, offering potential gains during semiconductor downturns but carrying significant decay and volatility risks. Investors should be cautious as the ETF is not suitable for long-term holdings due to its daily reset structure and inverse leverage, which can lead to substantial losses in rising markets.
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →